Allergic rhinitis is an immunologically mediated disease that occurs frequently worldwide and is caused by a type I hypersensitivity reaction (IgE-mediated) to allergenic substances. The clinical symptoms mainly include rhinorrhea (runny nose), sneezing, nasal obstruction (blocked nose), nasal itching and ocular discomfort (red, itchy, watery eyes). Although these symptoms are not usually life-threatening, the quality of life of those affected can be significantly impaired. Many patients also suffer from sleep problems, fatigue and difficulty concentrating, which has a negative impact on their professional performance and social life [1].
You May Also Like
- Brain health
News from the Swiss Brain Health Plan (SBHP) 2023-2033
- Friedreich's ataxia
Treatment options have improved
- Focus on prevention
Colorectal cancer screening – an update
- Late-Breaking Science
Antithrombotics & rhythm
- Prostate cancer
Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers